260 related articles for article (PubMed ID: 23062711)
1. Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors.
Qiu KM; Yan R; Xing M; Wang HH; Cui HE; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(22):6648-54. PubMed ID: 23062711
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors.
Alegaon SG; Hirpara MB; Alagawadi KR; Hullatti KK; Kashniyal K
Bioorg Med Chem Lett; 2014 Nov; 24(22):5324-9. PubMed ID: 25444084
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel pyrazole compounds.
Youssef AM; Neeland EG; Villanueva EB; White MS; El-Ashmawy IM; Patrick B; Klegeris A; Abd-El-Aziz AS
Bioorg Med Chem; 2010 Aug; 18(15):5685-96. PubMed ID: 20609589
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.
Wang HH; Qiu KM; Cui HE; Yang YS; Yin-Luo ; Xing M; Qiu XY; Bai LF; Zhu HL
Bioorg Med Chem; 2013 Jan; 21(2):448-55. PubMed ID: 23245802
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors.
Liu JJ; Zhang H; Sun J; Wang ZC; Yang YS; Li DD; Zhang F; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Oct; 20(20):6089-96. PubMed ID: 22985957
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Qiu KM; Wang HH; Wang LM; Luo Y; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Mar; 20(6):2010-8. PubMed ID: 22361272
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2).
Sharma SK; Al-Hourani BJ; Wuest M; Mane JY; Tuszynski J; Baracos V; Suresh M; Wuest F
Bioorg Med Chem; 2012 Apr; 20(7):2221-6. PubMed ID: 22386983
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; ElTahir KE
Bioorg Med Chem; 2012 May; 20(10):3306-16. PubMed ID: 22516672
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
Dube PN; Bule SS; Mokale SN; Kumbhare MR; Dighe PR; Ushir YV
Chem Biol Drug Des; 2014 Oct; 84(4):409-19. PubMed ID: 24636540
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
Grover J; Kumar V; Sobhia ME; Jachak SM
Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells.
Fang S; Huang X; Cai F; Qiu G; Lin F; Cai X
J Steroid Biochem Mol Biol; 2024 Jun; 240():106478. PubMed ID: 38430971
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
Bekhit AA; Ashour HM; Abdel Ghany YS; Bekhit Ael-D; Baraka A
Eur J Med Chem; 2008 Mar; 43(3):456-63. PubMed ID: 17532544
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
18. Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma.
Yu M; Yang H; Wu K; Ji Y; Ju L; Lu X
Bioorg Med Chem; 2014 Aug; 22(15):4109-18. PubMed ID: 24934992
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
20. Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
Al-Suwaidan IA; Alanazi AM; El-Azab AS; Al-Obaid AM; ElTahir KE; Maarouf AR; Abu El-Enin MA; Abdel-Aziz AA
Bioorg Med Chem Lett; 2013 May; 23(9):2601-5. PubMed ID: 23528298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
